Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug—induced DNA double strand breaks from DNA double strand breaks associated with apoptosis

@article{Dull2018DevelopmentOA,
  title={Development of a quantitative pharmacodynamic assay for apoptosis in fixed tumor tissue and its application in distinguishing cytotoxic drug—induced DNA double strand breaks from DNA double strand breaks associated with apoptosis},
  author={Angie B. Dull and Deborah F. Wilsker and Melinda G. Hollingshead and Christina N. Mazcko and Christina M Annunziata and Amy K LeBlanc and James H. Doroshow and Robert J. Kinders and Ralph E. Parchment},
  journal={Oncotarget},
  year={2018},
  volume={9},
  pages={17104 - 17116}
}
DNA double strand breaks (DSBs) induced by cancer therapeutic agents can lead to DNA damage repair or persistent DNA damage, which can induce apoptotic cell death; however, apoptosis also induces DSBs independent of genotoxic insult. γH2AX is an established biomarker for DSBs but cannot distinguish between these mechanisms. Activated cleaved caspase-3 (CC3) promotes apoptosis by enhancing nuclear condensation, DNA fragmentation, and plasma membrane blebbing. Here, we describe an… Expand
Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers
TLDR
The clinical utility of this DDR multiplex IFA has been demonstrated in preclinical models and clinical specimens following exposure to multiple classes of cytotoxic agents, DNA repair protein inhibitors, and molecularly targeted agents, in both homologous recombination–proficient and -deficient contexts. Expand
Smac-mimetic enhances antitumor effect of standard chemotherapy in ovarian cancer models via Caspase 8-independent mechanism
TLDR
It is shown that combination treatment with a Smac-mimetic can target tumor cells with low Caspase 8 and induce necroptotic cell death, and clinical validation of such approaches is needed to increase the effectiveness of current standard ovarian cancer treatment. Expand
Wee1 Inhibitor AZD1775 Combined with Cisplatin Potentiates Anticancer Activity against Gastric Cancer by Increasing DNA Damage and Cell Apoptosis
TLDR
The underlying mechanisms unveiled that the increased DNA damage indicated by increased γH2AX protein, as well as augmented cell apoptosis indicated by upregulated proapoptotic proteins, was responsible for the significant inhibitory effect of AZD1775 plus cisplatin. Expand
Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
TLDR
MerTK blockade increases tumor immunogenicity and potentiates anti-tumor immunity, which has implications for cancer immunotherapy. Expand
Benzothiazole derivative bearing amide moiety induces p53-mediated apoptosis in HPV16 positive cervical cancer cells
TLDR
Treatment of A-07 causes p53 and caspase dependent apoptosis in HPV 16 infected SiHa cells and it is demonstrated that the compound A- 07 leads to ROS generation and double strand breaks in SiHa and C-33A cells. Expand
NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma
TLDR
Results demonstrate proof-of-mechanism for indenoisoquinoline TOP1 inhibitors supporting their further clinical development and highlight the value of the NCI Comparative Oncology Program for evaluating novel therapies in immunocompetent pets with cancers. Expand
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors
TLDR
The once-daily adavosertib RPh2D was determined and activity was observed in patients with ovarian or endometrial carcinoma, including two with baseline CCNE1 mRNA overexpression, and future studies will determine whether CC NE1 overeexpression is a predictive biomarker for adavOSertib. Expand

References

SHOWING 1-10 OF 30 REFERENCES
The predominant role of apoptosis in γH2AX formation induced by aneugens is useful for distinguishing aneugens from clastogens.
TLDR
The aim of this study was to elucidate the influence of apoptosis on measurements of γH2AX by flow cytometry, with the clastogens mitomycin C and etoposide (ETP), and the aneugens vinblastine and paclitaxel (PT), which do not react directly with DNA. Expand
Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
TLDR
DAC could have a role in increasing the efficacy of chemotherapy for patients whose tumors lack MLH1 expression because of hMLH1 promoter methylation, and is consistent with loss of MMR having no effect on sensitivity in vitro to Taxol. Expand
Cell apoptosis: requirement of H2AX in DNA ladder formation, but not for the activation of caspase-3.
TLDR
Data indicated that H2AX phosphorylation is required for DNA ladder formation, but not for the activation of caspase-3; and the JNK/H2AX pathway cooperates with the casp enzyme-3/CAD pathway resulting in cellular apoptosis. Expand
Assessment of Apoptosis by Immunohistochemistry to Active Caspase-3, Active Caspase-7, or Cleaved PARP in Monolayer Cells and Spheroid and Subcutaneous Xenografts of Human Carcinoma
TLDR
Results support the assumption that c-PARP expression was dependent on treatment-induced apoptosis and shows the relevance of using antibodies that can discriminate caspase-dependent apoptotic pathways. Expand
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
TLDR
It is demonstrated for the first time that bivalent Smac mimetic Birinapant induces cell death as a single agent in TRAil-insensitive SUM190 (ErbB2-overexpressing) cells and significantly increases potency of TRAIL-induced apoptosis in TRAilsensitive SUM149 (triple-negative, EGFR-activated) cells. Expand
Development of a Validated Immunofluorescence Assay for γH2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity
TLDR
It is suggested that hair follicles may potentially serve as a surrogate tissue to evaluate tumor γH2AX response to Top1 inhibitors and will be used in correlative studies of two indenoisoquinolines in a phase I clinical trial at the National Cancer Institute. Expand
Major DNA Fragmentation Is a Late Event in Apoptosis
TLDR
The large temporal separation between nuclear morphological changes and major DNA fragmentation detectable by this in situ technique suggests caution in using in situ nick-translation as a direct correlate of internucleosomal DNA fragmentation in apoptosis. Expand
The nuclear γ-H2AX apoptotic ring: implications for cancers and autoimmune diseases
TLDR
The apoptotic ring is a thick intranuclear shell consisting of epigenetic modifications including histone H2AX and DNA damage response (DDR) proteins that excludes the DNA repair factors usually associated with γ-H2AX in the DDR nuclear foci. Expand
Comparison of immunohistochemistry for activated caspase‐3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC‐3 subcutaneous xenografts
TLDR
Activated caspase‐3 immunohistochemistry was an easy, sensitive, and reliable method for detecting and quantifying apoptosis in this model and is recommended for the detection and quantification of apoptotic cells in tissue sections. Expand
Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma
TLDR
In addition to its profound tumor-suppressive role, apoptosis can potentiate cancer progression and have important implications for understanding the fundamental biology of cell death, its roles in malignant disease, and the broader consequences of apoptosis-inducing anti-cancer therapy. Expand
...
1
2
3
...